檢索結果 - Eline Menu

Refine Results
  1. 1
    Exosomes in multiple myeloma: from bench to bedside

    Exosomes in multiple myeloma: from bench to bedside 由 Eline Menu, Karin Vanderkerken

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models

    Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models 由 Jinsong Hu, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, Karin Vanderkerken

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Metabolic Features of Multiple Myeloma

    Metabolic Features of Multiple Myeloma 由 Chaima El Arfani, Kim De Veirman, Ken Maes, Elke De Bruyne, Eline Menu

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Novel strategies to target the ubiquitin proteasome system in multiple myeloma

    Novel strategies to target the ubiquitin proteasome system in multiple myeloma 由 Susanne Lub, Ken Maes, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Els Van Valckenborgh

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    The therapeutic potential of cell cycle targeting in multiple myeloma

    The therapeutic potential of cell cycle targeting in multiple myeloma 由 Anke Maes, Eline Menu, Kim De Veirman, Ken Maes, Karin Vanderkerken, Elke De Bruyne

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

    Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma 由 Ken Maes, Eline Menu, Els Van Valckenborgh, Ivan Van Riet, Karin Vanderkerken, Elke De Bruyne

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model

    Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model 由 Eline Menu, Ron Kooijman, Els Van Valckenborgh, Kewal Asosingh, Marleen Bâkkus, B Van Camp, Karin Vanderkerken

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

    Fueling CARs: metabolic strategies to enhance CAR T-cell therapy 由 Arne Van der Vreken, Karin Vanderkerken, Elke De Bruyne, Kim De Veirman, Karine Breckpot, Eline Menu

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response

    The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response 由 Eva De Smedt, Hui Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

    Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma 由 Jinheng Wang, Sylvia Faict, Ken Maes, Elke De Bruyne, Els Van Valckenborgh, Rik Schots, Karin Vanderkerken, Eline Menu

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition

    Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition 由 Jinsong Hu, Nana Dang, Eline Menu, Elke De Bryune, Dehui Xu, Ben Van Camp, Els Van Valckenborgh, Karin Vanderkerken

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

    The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells 由 Jinheng Wang, Kim De Veirman, Nathan De Beule, Ken Maes, Elke De Bruyne, Els Van Valckenborgh, Karin Vanderkerken, Eline Menu

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms

    IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms 由 Elke De Bruyne, Tomas Bos, Frans Schuit, Els Van Valckenborgh, Eline Menu, Lieven Thorrez, Peter Atadja, Helena Jernberg‐Wiklund, Karin Vanderkerken

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma

    The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma 由 Ken Maes, Eva De Smedt, Miguel Lemaire, Hendrik De Raeve, Eline Menu, Els Van Valckenborgh, Steve Mcclue, Karin Vanderkerken, Elke De Bruyne

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Bone marrow stromal cell–derived exosomes as communicators in drug resistance in multiple myeloma cells

    Bone marrow stromal cell–derived exosomes as communicators in drug resistance in multiple myeloma cells 由 Jinheng Wang, An Hendrix, Sophie Hernot, Miguel Lemaire, Elke De Bruyne, Els Van Valckenborgh, Tony Lahoutte, Olivier De Wever, Karin Vanderkerken, Eline Menu

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

    Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions 由 Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

    Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies 由 Kim De Veirman, Els Van Valckenborgh, Qods Lahmar, Xenia Geeraerts, Elke De Bruyne, Eline Menu, Ivan Van Riet, Karin Vanderkerken, Jo A. Van Ginderachter

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential

    The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential 由 Liesbeth Bieghs, Hans Erik Johnsen, Ken Maes, Eline Menu, Els Van Valckenborgh, Michael T. Overgaard, Mette Nyegaard, Cheryl A. Conover, Karin Vanderkerken, Elke De Bruyne

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

    Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model 由 Eline Menu, Helena Jernberg‐Wiklund, Thomas Strömberg, Hendrik De Raeve, Leonard Girnita, Olle Larsson, Magnus Axelson, Kewal Asosingh, Kenneth Nilsson, Ben Van Camp, Karin Vanderkerken

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

    Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis 由 Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, Eline Menu

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: